Table 1. Patient characteristics.
| Characteristic | Normal Subjects (n = 12) | MZL (n = 7) | BNHL (n = 9) | |
|---|---|---|---|---|
| Age (Years) | Mean (Range) | 33.3 (25–65) | 71.9 (54–84) | 63.7 (43–81) |
| Number <40 (%) | 9 (75%) | |||
| Number >40 (%) | 3 (25%) | 7 (100%) | 9 (100%) | |
| Gender | Male | 7 (58%) | 4 (57%) | 5 (55%) |
| Female | 5 (42%) | 3 (43%) | 4 (45%) | |
| Diagnosis | MZL | 7 | ||
| FL | 6 | |||
| B-NHL-NOS | 1 | |||
| LL | 2 | |||
| Clinical Stage | I | 1 | 1 | |
| II | 1 | 1 | ||
| III | 1 | 2 | ||
| IV | 4 | 5 | ||
Patients were divided into two categories: marginal zone lymphoma (MZL) and low-grade B-cell non-Hodgkin’s lymphoma (BNHL). BNHL, in turn, includes follicular lymphoma (FL), lymphoplasmacytoid lymphoma (LL) and B-cell non-Hodgkin’s lymphoma not otherwise specified (BNHL-NOS). MZL cases comprised nodal MZL (n = 3), extra-nodal MZL (n = 3) and splenic marginal zone lymphoma (n = 1). All MZL cases were CD5- and CD10-.